Categories: Drugs/Metabolism

What Antibiotics interfere with OCP?

  1. Rifampin is the antibiotic that is classically stated to be avoided in women taking OCPs

HOW? Rifampin is a potent inducer of cytochrome P450 3A4 and accelerates the elimination of ethinyl estradiol and some progestin components, resulting in an increased risk of OCP failure

OTHER DRUGS TO AVOID: Griseofulvin (an antifungal), Phenytoin, St. John’s Wort and Chronic Alcohol use (can all induce CYP 3A4)

References

1. Barditch-Crovo P, Trapnell CB, Ette E et al (1999) The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clin Pharmacol Ther 65:428–438

2. Pelkonen, Olavi et al. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch. Toxicol. October 2008, Volume 82, Issue 10, pp 667-715

Get Medical Pearls directly to your inbox every week!
Weekly posts with high yield medical knowledge, directly to your mailbox!
Dr. C Humphreys

Internal Medicine

Recent Posts

Mechanism of a Mixed Apnea

Mixed apneas are characterized by absent respiratory effort and airflow in the first section of…

2 months ago

How Does Hypothyroidism Cause Hypoventilation?

Although rare, the differential diagnosis of hypoventilation and hypercapnia respiratory failure includes hypothyroidism. It is…

2 months ago

Why is Pro-BNP/ BNP lower in Obesity?

B-type natriuretic peptide (BNP) is a hormone created in response to cardiac wall stretch due…

8 months ago

What is Peribronchovascular Distribution on CT imaging?

A common finding described on computed tomography (CT) imaging. A disease with a peribronchovascular distribution…

1 year ago

Trapped Lung vs. Lung Entrapment

Though often used synonymously; Trapped Lung and Lung Entrapment technically describe separate entities along the…

2 years ago

Cause of Pericardial Effusion in Pulmonary Hypertension: Pathogenesis

It is not clearly understood why patients with pulmonary hypertension (PH) develop pericardial effusions. However,…

2 years ago

This website uses cookies.